Ocuphire Pharma Revenue 2010-2024 | IRD
Ocuphire Pharma revenue from 2010 to 2024. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
| Ocuphire Pharma Annual Revenue (Millions of US $) |
|
|---|---|
| 2023 | $19 |
| 2022 | $40 |
| 2021 | $1 |
| 2020 | $ |
| 2019 | $ |
| 2018 | $ |
| 2017 | $ |
| 2016 | $ |
| 2015 | $ |
| 2014 | $ |
| 2013 | $ |
| 2012 | $ |
| 2011 | $ |
| 2010 | $ |
| 2009 | $ |
| Ocuphire Pharma Quarterly Revenue (Millions of US $) |
|
|---|---|
| 2024-06-30 | $1 |
| 2024-03-31 | $2 |
| 2023-12-31 | $2 |
| 2023-09-30 | $12 |
| 2023-06-30 | $4 |
| 2023-03-31 | $2 |
| 2022-12-31 | |
| 2022-09-30 | |
| 2022-06-30 | |
| 2022-03-31 | |
| 2021-12-31 | $0 |
| 2021-09-30 | $0 |
| 2021-06-30 | $0 |
| 2021-03-31 | |
| 2020-12-31 | |
| 2020-09-30 | |
| 2020-06-30 | |
| 2020-03-31 | |
| 2019-12-31 | |
| 2019-09-30 | |
| 2019-06-30 | |
| 2019-03-31 | |
| 2018-12-31 | |
| 2018-09-30 | |
| 2018-06-30 | |
| 2018-03-31 | |
| 2017-12-31 | |
| 2017-09-30 | |
| 2017-06-30 | |
| 2017-03-31 | |
| 2016-12-31 | |
| 2016-09-30 | |
| 2016-06-30 | |
| 2016-03-31 | |
| 2015-12-31 | |
| 2015-09-30 | |
| 2015-06-30 | |
| 2015-03-31 | |
| 2014-12-31 | |
| 2014-09-30 | |
| 2014-06-30 | |
| 2014-03-31 | |
| 2013-12-31 | |
| 2013-09-30 | |
| 2013-06-30 | |
| 2013-03-31 | |
| 2012-12-31 | |
| 2012-09-30 | |
| 2012-06-30 | |
| 2012-03-31 | |
| 2011-12-31 | |
| 2011-09-30 | |
| 2011-06-30 | |
| 2011-03-31 | |
| 2010-12-31 | |
| 2010-09-30 | |
| 2010-06-30 | $0 |
| 2010-03-31 | $0 |
| 2009-12-31 | |
| 2009-09-30 | $0 |
| 2009-06-30 | $0 |
| 2009-03-31 | $0 |
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Fanhua (AIFU) | China | $0.086B | 2.07 |
| Top KingWin (WAI) | China | $0.008B | 0.00 |
| S&W Seed (SANW) | United States | $0.006B | 0.00 |
| Invo BioScience (NAYA) | United States | $0.004B | 0.00 |